Results

Total Results: 2,463 records

Showing results for "testing".

21. Reliability Testing of the AHRQ EPC Approach to Grading the Strength of Evidence in Comparative Effectiveness Reviews | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/reliability-testing-grading-evidence/research
    May 22, 2012 - Reliability Testing of the AHRQ EPC Approach to Grading the Strength of Evidence in Comparative Effectiveness … Our project focused on inter-rater reliability testing of the two main components of the AHRQ approach … Data Sources and Methods We conducted inter-rater reliability testing using data obtained from two

22. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research
    March 29, 2016 - 2012 Topic Suggestion Jan. 15, 2015 Research Protocol Mar. 29, 2016 Systematic Review Noninvasive Testing … Revascularization referral was more common following CCTA versus functional testing in general (high … In ED settings, additional testing was more common following CCTA than following SPECT (high strength … or further testing was not described in RCTs. … regarding exposure for the initial test or downstream testing.

23. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
    May 19, 2010 - Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing … had both reliability and validity issues, leaving a set of 41 indicators most promising for further testing … communication are very different from those assessing discrete, concrete events like fecal occult blood testing … Cancer Quality-ASSIST supportive oncology quality indicator set: feasibility, reliability, and validity testing

24. Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/genetic-testing-developmental-disabilities/technical-brief
    June 30, 2015 - Research Protocol Jun. 30, 2015 Technical Brief Nov. 3, 2015 Disposition of Comments Report Genetic Testing … We searched the National Center for Biotechnology Information's Genetic Testing Registry (GTR) to identify … Common genetic testing methods used include array comparative genomic hybridization, microarray, DNA … We did not identify any studies that directly assessed the impact of genetic testing on health outcomes

25. Fecal DNA Testing in Screening for Colorectal Cancer in Average Risk Adults | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/colorectal-cancer-screening/research
    February 29, 2012 - Research Protocol Feb. 29, 2012 Systematic Review May. 17, 2012 Disposition of Comments Report Fecal DNA Testing … Structured Abstract Objectives To review the evidence on fecal DNA testing to screen for colorectal … We found no studies that specifically evaluated the harms of fecal DNA testing. … There is also insufficient evidence for the harms, analytic validity, and acceptability of testing in … Existing evidence has little or no applicability to currently available fecal DNA testing.

26. End of Life Issues | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/end-life-issues
    May 17, 2010 - Testing Cancer Quality Measures for End-of-Life Care Research Report Archived May 17, … Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing

27. Health Facilities | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/health-facilities
    November 15, 2011 - The AHRQ Evidence-Based Care (EBC) Challenge Research Report June 1, 2013 Testing … Aureus (MRSA) Systematic Review Archived June 20, 2013 Routine Preoperative Testing … in Shared Decision Making (Session III) White Paper September 30, 2013 PCA3 Testing … Aggression in Dementia Systematic Review Archived March 21, 2016 Noninvasive Testing … Coronary Artery Disease Systematic Review Archived March 29, 2016 Noninvasive Testing

28. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research-protocol/

29. Genetic Testing for Developmental and Intellectual Disabilities | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/genetic-testing-developmental-disabilities/research-protocol/

30. Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/dcis-prognostic-tests/research
    September 13, 2012 - Rates of testing varied significantly across race groups for all tests. … Neither study included ER testing. … ER testing is considered standard of care for women with early invasive cancer. … Studies of PR testing are inconclusive in the context of DCIS. … and to better understand how testing rates differ between both groups.

31. Key Questions 1. Does routine preoperative testing compared to no testing or alternative testing strategies improve outcomes (such as surgical complications, other morbidity, and mortality) among patients undergoing elective surgery? 2.… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surg

32. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
    August 22, 2012 - Estrogen and Progesterone Receptor Testing Rates of ER/PR testing for women with DCIS varied strongly … HER2 Testing As with ER/PR testing, HER2 testing increased dramati- cally among women with DCIS between … BRCA Testing We found a low rate (0.6%) of BRCA testing among women with DCIS. … and are thus testing randomly. … Data Points • # 15 • Breast Cancer Diagnostic Workup 14 Appendix D: ER/PR testing and HER2 testing

33. Health Occupations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/health-occupations
    January 17, 2012 - Implants for Aortic Valve Disease Research Report March 28, 2013 Reliability Testing … Osteoarthritis: Future Research Needs Systematic Review Archived February 1, 2013 PCA3 Testing … Global Health Evidence Evaluation Framework White Paper June 24, 2013 Genetic Testing … Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing … September 30, 2012 Additional Patient Outcomes and Alternative Pathways in Evaluations of Testing

34. Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
    March 13, 2013 - Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ … § Genetic Testing for Developmental Diseases Nomination Summary Document … Results of Topic Selection Process & Next Steps  The topic, Genetic Testing … Comparator(s): Other genetic testing/no genetic testing Outcome(s): Changes to child treatment specific …  Given the limited available evidence, the rapid pace of change in genetic testing, and the recent

35. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
    January 01, 2009 - Some effects from testing are direct. … A study of genetic testing for BRCA1 and BRCA2 found that women testing positive for a mutation reported … Behavioral Effects of Testing The emotional, social, and cognitive effects of testing may also affect … In this, testing is no exception. … Most of these frameworks look at determinants of testing, however, not at the effects of testing.

36. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research
    September 25, 2013 - 2011 Research Protocol Sep. 25, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Testing … for CYP2C19 variants and phenotypic testing to measure platelet reactivity) to identify patients who … (for CYP2C19 variants) or phenotypic testing (for platelet reactivity). … One hundred six studies provided information on the ability of genetic testing for CYP2C19 variants to … treatment choice: 1 randomized trial of testing versus no testing, 12 randomized treatment trials assessing

37. Executive Summary CER 171: Noninvasive Testing for Coronary Artery Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
    March 01, 2011 - Additional Noninvasive Testing Additional noninvasive testing, which impacts the cost and efficiency … Harms and Consequences of Testing Harms of testing were rarely reported and details on comparisons of … No studies that compared testing with an arm that received no testing were identified, so the impact … Studies comparing testing versus clinical evaluation without testing would provide valuable information … for assessing the need for testing, possible overuse of testing, and the impact of testing in general

38. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - Testing in these two situations should be looked at separately. … when compared with no testing. … that no testing for any underlying diagnosis is worthwhile. … They may do focused/targeted aCGH/microarray testing. … Good example of potential risk of testing?

39. For women, when comparing noninvasive testing,which testing method (echocardiography, MIBI-SPECT, pharmacological testing, etc.) is more accurate in diagnosing coronary artery disease. There has been inadequate studies done on women for… | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-

40. 13-MDM347013 30..38 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
    January 01, 2009 - Some effects from testing are direct. … A study of genetic testing for BRCA1 and BRCA2 found that women testing positive for a mutation reported … Behavioral Effects of Testing The emotional, social, and cognitive effects of testing may also affect … In this, testing is no exception. … Most of these frameworks look at determinants of testing, however, not at the effects of testing.